Dr. Merchant will also be available to meet with investors on a one-on-one basis during the conference.
TORONTO and HOUSTON, June 19, 2019 /PRNewswire/ - Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, is pleased to announce that Dr. Fahar Merchant, Chairman, President and CEO will present an overview of the Company at the Raymond James Life Sciences and MedTech Conference today, Wednesday, June 19th at 8:00 AM ET at the Lotte New York Palace hotel in New York City. Dr. Merchant will also be available to meet with investors on a one-on-one basis during the conference. This presentation will be made available with a live webcast and may be accessed on the Events & Presentations page by visiting Medicenna’s website at https://ir.medicenna.com/. This webcast will be available for 7 days following the presentation. About Medicenna
SOURCE Medicenna Therapeutics Corp. | ||
Company Codes: OTC-QX:MDNAF, Toronto:MDNA |